MEDNAX Business Update Conference Call/Webcast Scheduled for Friday, June 5, 2020
June 01 2020 - 4:15PM
Business Wire
MEDNAX, Inc. (NYSE: MD), will host an investor conference call
and webcast on Friday, June 5, 2020 at 9:00 a.m. ET, to provide a
business update. A detailed press release will be issued the
morning of June 5, 2020 before the securities markets open.
The investor conference call will be webcast and can be accessed
at MEDNAX’s website, www.mednax.com/investors.
ABOUT MEDNAX
MEDNAX, Inc. is a national health solutions partner comprised of
the nation's leading providers of physician services. Physicians
and advanced practitioners practicing as part of MEDNAX are
reshaping the delivery of care within their specialties and
subspecialties, using evidence-based tools, continuous quality
initiatives, consulting services, clinical research and
telemedicine to enhance patient outcomes and provide high-quality,
cost-effective care. The Company was founded in 1979, and today,
through its affiliated professional corporations, MEDNAX provides
services through a network of more than 3,000 physicians in all 50
states and Puerto Rico. Additional information is available at
www.mednax.com.
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995, Section 27A
of the Securities Act of 1933, as amended (the “Securities Act”),
and Section 21E of the Securities Exchange Act of 1934, as amended.
Forward-looking statements may include, but are not limited to,
statements relating to the Company’s objectives, plans and
strategies, and all statements, other than statements of historical
facts, that address activities, events or developments that we
intend, expect, project, believe or anticipate will or may occur in
the future. These statements are often characterized by terminology
such as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,”
“plan,” “will,” “expect,” “estimate,” “project,” “positioned,”
“strategy” and similar expressions, and are based on assumptions
and assessments made by the Company’s management in light of their
experience and their perception of historical trends, current
conditions, expected future developments and other factors they
believe to be appropriate. Any forward-looking statements in this
press release are made as of the date hereof, and the Company
undertakes no duty to update or revise any such statements, whether
as a result of new information, future events or otherwise.
Forward-looking statements are not guarantees of future performance
and are subject to risks and uncertainties. Important factors that
could cause actual results, developments, and business decisions to
differ materially from forward-looking statements are described in
the Company’s most recent Annual Report on Form 10-K and its
Quarterly Reports on Form 10-Q, including the sections entitled
“Risk Factors”, as well the Company’s current reports on Form 8-K,
filed with the Securities and Exchange Commission, and include the
and include the impact of the COVID-19 outbreak on the Company and
its financial condition and results of operations; the effects of
economic conditions on MEDNAX’s business; the effects of the
Affordable Care Act and potential changes thereto or a repeal
thereof; MEDNAX’s relationships with government-sponsored or funded
healthcare programs, including Medicare and Medicaid, and with
managed care organizations and commercial health insurance payors;
the impact of the divestiture of the Company’s anesthesiology
medical group; the timing and contribution of future acquisitions;
the effects of share repurchases; and the effects of MEDNAX’s
transformation and restructuring initiatives.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200601005696/en/
Charles Lynch Vice President, Strategy and Investor Relations
954-384-0175, x 5692 charles_lynch@mednax.com
Pediatrix Medical (NYSE:MD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pediatrix Medical (NYSE:MD)
Historical Stock Chart
From Apr 2023 to Apr 2024